Profil bibliographique

Martin Štěrba

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

129Publications signalées

4573Citations signalées

3Affiliations récentes

Institutions déclarées

Charles University University Hospital Hradec Králové University of Hradec Králové

Domaines associés

Chemotherapy-induced cardiotoxicity and mitigationCardiac Ischemia and ReperfusionChemotherapy-induced organ toxicity mitigationCancer therapeutics and mechanismsCancer Treatment and Pharmacology

Publications récentes

Accès ouvert 2026 article

sGC stimulator BAY 41‐8543 improves survival and ventricular function in a rat model of doxorubicin‐induced cardiomyopathy with nephrotic syndrome

Olga Gawryś, Petra Škaroupková, Soňa Kikerlová, Zdeňka Vaňourková et autres

0 citationsBritish Journal of Pharmacology

2026 article

Structure-Guided Development of Topoisomerase IIB Isoform-Selective Inhibitors for Prevention of Anthracycline Cardiotoxicity (Abstract ID: 270109)

Anh Cong, Caroline A. Austin, Martin Štěrba, Tomáš Šimůnek et autres

0 citationsJournal of Pharmacology and Experimental Therapeutics

Accès ouvert 2025 article

Prenatal paroxetine dysregulates monoamine homeostasis and affects placental hemodynamics in the rat fetoplacental unit

Hana Horackova, Ivana Musilova-Kacerovska, Cilia Abad, Rona Karahoda et autres

2 citationsBiomedicine & Pharmacotherapy

Accès ouvert 2025 conference-abstract

Topobexin Targets a Unique Druggable Pocket of Topoisomerase II for Beta Isoform- Selective Control of DNA Damage During Anthracycline Chemotherapy

Jan Kubeš, Galina Karabanovich, Anh Cong, Iuliia Melnikova et autres

0 citationsStructural Dynamics

Accès ouvert 2025 article

Daunorubicin and its hydroxy metabolite in cardiomyocytes: insights into cellular kinetics, toxicity, DNA damage, and dexrazoxane-induced cardioprotection

Lenka Applová, Paulína Dudášová-Hatoková, Jan Kubeš, Nela Váňová et autres

1 citationArchives of Toxicology

Accès ouvert 2025 article

Topobexin targets the Topoisomerase II ATPase domain for beta isoform-selective inhibition and anthracycline cardioprotection

Jan Kubeš, Galina Karabanovich, Anh Cong, Iuliia Melnikova et autres

15 citationsNature Communications

Accès ouvert 2025 article

Impact of intraamniotic inflammation on tryptophan metabolism in the placenta-fetal brain axis in rats

Cilia Abad, Ivana Musilová, Eva Cifkova, Ramón Portillo et autres

3 citationsReproduction

Accès ouvert 2025 article

Methodological Aspects of μLC-MS/MS for Wide-Scale Proteomic Analysis of Anthracycline-Induced Cardiomyopathy

Rudolf Kupčík, Olga Lenčová, Yvona Mazurová, Martin Štěrba et autres

2 citationsACS Omega

Accès ouvert 2024 article

Volumetric absorptive microsampling meets electromembrane extraction for the first time: Case example of doxorubicin and its metabolite in whole blood samples

Adam Reguli, Hana Bavlovič Piskáčková, Olga Lenčová-Popelová, Petra Kollárová-Brázdová et autres

6 citationsAnalytica Chimica Acta

Accès ouvert 2024 article

Characterization of a new model of chemotherapy-induced heart failure with reduced ejection fraction and nephrotic syndrome in Ren-2 transgenic rats

Olga Gawryś, Šárka Jíchová, Matúš Miklovič, Zuzana Husková et autres

5 citationsHypertension Research

Accès ouvert 2024 article

Exploring the effects of topoisomerase II inhibitor XK469 on anthracycline cardiotoxicity and DNA damage

Veronika Keresteš, Jan Kubeš, Lenka Applová, Petra Kollárová-Brázdová et autres

9 citationsToxicological Sciences

Accès ouvert 2024 article

Cardiac miRNA expression during the development of chronic anthracycline-induced cardiomyopathy using an experimental rabbit model

Michaela Adamcová, Helena Párová, Olga Lenčová-Popelová, Petra Kollárová-Brázdová et autres

8 citationsFrontiers in Pharmacology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.